378 related articles for article (PubMed ID: 12071123)
1. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye H
Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
[No Abstract] [Full Text] [Related]
2. Sitagliptin/metformin (Janumet) for type 2 diabetes.
Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377
[No Abstract] [Full Text] [Related]
3. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
Hitt CM
Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
[No Abstract] [Full Text] [Related]
4. [Characteristic of metformin for treatment of impaired glucose tolerance].
Ishida W; Satoh J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():433-7. PubMed ID: 15779418
[No Abstract] [Full Text] [Related]
5. [Biguanides in oral antidiabetic therapy: indications and limitations].
Gregorio F; Filipponi P
Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
[No Abstract] [Full Text] [Related]
6. [Adverse effect of biguanides].
Yamasaki Y; Kuroda A
Nihon Rinsho; 2002 Sep; 60 Suppl 9():389-92. PubMed ID: 12387023
[No Abstract] [Full Text] [Related]
7. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
8. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
9. [Therapeutic utility of biguanides in the treatment of NIDDM].
Fujimoto S
Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone/metformin (Actoplus met).
Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
[No Abstract] [Full Text] [Related]
11. Use of metformin in pediatric age.
Brufani C; Fintini D; Nobili V; Patera PI; Cappa M; Brufani M
Pediatr Diabetes; 2011 Sep; 12(6):580-8. PubMed ID: 21366813
[No Abstract] [Full Text] [Related]
12. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
13. Metaglip and Avandamet for type 2 diabetes.
Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
[No Abstract] [Full Text] [Related]
14. [Biguanides in the treatment of diabetes mellitus].
Saraiva AM
Acta Med Port; 1989 Sep; Suppl 1():15S-18S. PubMed ID: 2694769
[TBL] [Abstract][Full Text] [Related]
15. [On the clinical use of biguanides].
Haese E
Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
[No Abstract] [Full Text] [Related]
16. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
17. Metformin in type 2 diabetes.
Fox GN
J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
[No Abstract] [Full Text] [Related]
18. Metformin lactic acidosis and anaesthesia: myth or reality?
Vreven R; De Kock M
Acta Anaesthesiol Belg; 2005; 56(3):297-302. PubMed ID: 16265833
[TBL] [Abstract][Full Text] [Related]
19. Metformin use and diabetic pregnancy-has its time come?
Hawthorne G
Diabet Med; 2006 Mar; 23(3):223-7. PubMed ID: 16492202
[TBL] [Abstract][Full Text] [Related]
20. [Structure and mechanisms of action of biguanides].
Fujimoto S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():377-81. PubMed ID: 12387021
[No Abstract] [Full Text] [Related]
[Next] [New Search]